Elevance Health Inc.ELVNYSE
Loading
EBITDA Over TimeStable
Percentile Rank71
3Y CAGR-1.6%
5Y CAGR+3.4%
Year-over-Year Change
Earnings before interest, taxes, depreciation, and amortization
3Y CAGR
-1.6%/yr
vs +9.9%/yr prior
5Y CAGR
+3.4%/yr
Recent deceleration
Acceleration
-11.4pp
Decelerating
Percentile
P71
Within normal range
vs 5Y Ago
1.2x
Modest growth
Streak
2 yr
Consecutive declineStable
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $9.66B | -7.9% |
| 2024 | $10.48B | -0.1% |
| 2023 | $10.49B | +3.6% |
| 2022 | $10.13B | +1.0% |
| 2021 | $10.03B | +22.6% |
| 2020 | $8.18B | +4.0% |
| 2019 | $7.86B | +13.1% |
| 2018 | $6.95B | +24.3% |
| 2017 | $5.59B | -9.6% |
| 2016 | $6.19B | - |